Close Menu

NEW YORK (GenomeWeb) – CellMax Life's focus on developing a blood-based cell detection platform to detect pre-cancer and cancer at an early stage is one of its main differentiating points in an increasingly crowded market, a company executive said last week on the sidelines of the 37th annual JP Morgan Healthcare Conference.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.